Showing results (1251-1260 of 1,360) with videos related to

Sort By:
Pageof 136
Neuron|June 9, 2014
SorCS2 regulates dopaminergic wiring and is processed into an apoptotic two-chain receptor in peripheral gliaSimon Glerup, Ditte Olsen, Christian B Vaegter, et al.
Plos Genetics|August 31, 2019
A region-based gene association study combined with a leave-one-out sensitivity analysis identifies SMG1 as a pancreatic cancer susceptibility geneCavin Wong, Fei Chen, Najmeh Alirezaie, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|August 3, 2020
Gallbladder disease, cholecystectomy, and pancreatic cancer risk in the International Pancreatic Cancer Case-Control Consortium (PanC4)Valentina Rosato, Eva Negri, Cristina Bosetti, et al.
Cancer Causes & Control : CCC|January 5, 2011
Cohorts and consortia conference: a summary report (Banff, Canada, June 17-19, 2009)Paolo Boffetta, Graham A Colditz, John D Potter, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 20, 2016
Association of Common Susceptibility Variants of Pancreatic Cancer in Higher-Risk Patients: A PACGENE StudyErica J Childs, Kari G Chaffee, Steven Gallinger, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 20, 2009
Functional and clinical significance of variants localized to 8q24 in colon cancerMine S Cicek, Susan L Slager, Sara J Achenbach, et al.
Pancreas|August 13, 2016
Pancreatic Cancer Chemoprevention Translational Workshop: Meeting ReportMark Steven Miller, Peter Allen, Teresa A Brentnall, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 3, 2020
Comparative analysis of acute toxicities and patient reported outcomes between intensity-modulated proton therapy (IMPT) and volumetric modulated arc therapy (VMAT) for the treatment of oropharyngeal cancerGohar S Manzar, Scott C Lester, David M Routman, et al.
Blood|June 25, 2011
Prolonged half-life and preserved enzymatic properties of factor IX selectively PEGylated on native N-glycans in the activation peptideHenrik Østergaard, Jais R Bjelke, Lene Hansen, et al.
Mucosal Immunology|August 3, 2017
The TLR9 agonist MGN1703 triggers a potent type I interferon response in the sigmoid colonA R Krarup, M Abdel-Mohsen, M H Schleimann, et al.
Pageof 136